Patents by Inventor Renato A. Chiarella

Renato A. Chiarella has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Immediate release multilayer tablet
    Patent number: 11951111
    Abstract: Described herein, in part, are tablets, such as immediate release multi-layer or bilayer tablets for orally delivering olanzapine and samidorphan, methods of using said tablets in the treatment of disorders described herein, and kits comprising said tablets.
    Type: Grant
    Filed: June 1, 2023
    Date of Patent: April 9, 2024
    Assignee: Alkermes Pharma Ireland Limited
    Inventors: Renato A. Chiarella, Hector Guzman, Paul Hurley, David Manser, Kristopher Perkin
  • IMMEDIATE RELEASE MULTILAYER TABLET
    Publication number: 20240091237
    Abstract: Described herein, in part, are tablets, such as immediate release multi-layer or bilayer tablets for orally delivering olanzapine and samidorphan, methods of using said tablets in the treatment of disorders described herein, and kits comprising said tablets.
    Type: Application
    Filed: November 15, 2023
    Publication date: March 21, 2024
    Inventors: Renato A. Chiarella, Hector Guzman, Paul Hurley, David Manser, Kristopher Perkin
  • IMMEDIATE RELEASE MULTILAYER TABLET
    Publication number: 20240082257
    Abstract: Described herein, in part, are tablets, such as immediate release multi-layer or bilayer tablets for orally delivering olanzapine and samidorphan, methods of using said tablets in the treatment of disorders described herein, and kits comprising said tablets.
    Type: Application
    Filed: November 15, 2023
    Publication date: March 14, 2024
    Inventors: Renato A. Chiarella, Hector Guzman, Paul Hurley, David Manser, Kristopher Perkin
  • Crystallization process of aripiprazole derivatives in extended release formulations for treatment of schizophrenia
    Patent number: 11883394
    Abstract: Processes for providing depot injections of recrystallized aripiprazole lauroxil in which particles of the aripiprazole lauroxil have a surface area of about 0.50 to about 3.3 m2/g; and crystals of aripiprazole lauroxil produced by such processes.
    Type: Grant
    Filed: March 24, 2021
    Date of Patent: January 30, 2024
    Assignee: ALKERMES PHARMA IRELAND LIMITED
    Inventors: Wilfredo Morales, Tarek A. Zeidan, Renato A. Chiarella, Steven G. Wright, Jason M. Perry
  • IMMEDIATE RELEASE MULTILAYER TABLET
    Publication number: 20230310451
    Abstract: Described herein, in part, are tablets, such as immediate release multi-layer or bilayer tablets for orally delivering olanzapine and samidorphan, methods of using said tablets in the treatment of disorders described herein, and kits comprising said tablets.
    Type: Application
    Filed: June 1, 2023
    Publication date: October 5, 2023
    Inventors: Renato A. Chiarella, Hector Guzman, Paul Hurley, David Manser, Kristopher Perkin
  • Immediate release multilayer tablet
    Patent number: 11707466
    Abstract: Described herein, in part, are tablets, such as immediate release multi-layer or bilayer tablets for orally delivering olanzapine and samidorphan, methods of using said tablets in the treatment of disorders described herein, and kits comprising said tablets.
    Type: Grant
    Filed: June 30, 2022
    Date of Patent: July 25, 2023
    Assignee: Alkermes Pharma Ireland Limited
    Inventors: Renato A. Chiarella, Hector Guzman, Paul Hurley, David Manser, Kristopher Perkin
  • IMMEDIATE RELEASE MULTILAYER TABLET
    Publication number: 20220354866
    Abstract: Described herein, in part, are tablets, such as immediate release multi-layer or bilayer tablets for orally delivering olanzapine and samidorphan, methods of using said tablets in the treatment of disorders described herein, and kits comprising said tablets.
    Type: Application
    Filed: June 30, 2022
    Publication date: November 10, 2022
    Inventors: Renato A. Chiarella, Hector Guzman, Paul Hurley, David Manser, Kristopher Perkin
  • CRYSTALLIZATION PROCESS OF ARIPIPRAZOLE DERIVATIVES IN EXTENDED RELEASE FORMULATIONS FOR TREATMENT OF SCHIZOPHRENIA
    Publication number: 20210205302
    Abstract: Processes for providing depot injections of recrystallized aripiprazole lauroxil in which particles of the aripiprazole lauroxil have a surface area of about 0.50 to about 3.3 m2/g; and crystals of aripiprazole lauroxil produced by such processes.
    Type: Application
    Filed: March 24, 2021
    Publication date: July 8, 2021
    Inventors: Wilfredo Morales, Tarek A. Zeidan, Renato A. Chiarella, Steven G. Wright, Jason M. Perry
  • Crystallization process of aripiprazole derivatives in extended release formulations for treatment of schizophrenia
    Patent number: 10973816
    Abstract: Processes for providing depot injections of recrystallized aripiprazole lauroxil in which particles of the aripiprazole lauroxil have a surface area of about 0.50 to about 3.3 m2/g; and crystals of aripiprazole lauroxil produced by such processes.
    Type: Grant
    Filed: October 8, 2019
    Date of Patent: April 13, 2021
    Assignee: ALKERMES PHARMA IRELAND LIMITED
    Inventors: Wilfredo Morales, Tarek A. Zeidan, Renato A. Chiarella, Steven G. Wright, Jason M. Perry
  • CRYSTALLIZATION PROCESS OF ARIPIPRAZOLE DERIVATIVES IN EXTENDED RELEASE FORMULATIONS FOR TREATMENT OF SCHIZOPHRENIA
    Publication number: 20200108063
    Abstract: Processes for providing depot injections of recrystallized aripiprazole lauroxil in which particles of the aripiprazole lauroxil have a surface area of about 0.50 to about 3.3 m2/g; and crystals of aripiprazole lauroxil produced by such processes.
    Type: Application
    Filed: October 8, 2019
    Publication date: April 9, 2020
    Inventors: Wilfredo Morales, Tarek A. Zeidan, Renato A. Chiarella, Steven G. Wright, Jason M. Perry
  • Crystallization process of aripiprazole derivatives in extended release formulations for treatment of schizophrenia
    Patent number: 10478434
    Abstract: Processes for providing depot injections of recrystallized aripiprazole lauroxil in which particles of the aripiprazole lauroxil have a surface area of about 0.50 to about 3.3 m2/g; and crystals of aripiprazole lauroxil produced by such processes.
    Type: Grant
    Filed: July 24, 2018
    Date of Patent: November 19, 2019
    Assignee: ALKERMES PHARMA IRELAND LIMITED
    Inventors: Wilfredo Morales, Tarek A. Zeidan, Renato A. Chiarella, Steven G. Wright, Jason M. Perry
  • CRYSTALLIZATION PROCESS OF ARIPIPRAZOLE DERIVATIVES IN EXTENDED RELEASE FORMULATIONS FOR TREATMENT OF SCHIZOPHRENIA
    Publication number: 20190015408
    Abstract: Processes for providing depot injections of recrystallized aripiprazole lauroxil in which particles of the aripiprazole lauroxil have a surface area of about 0.50 to about 3.3 m2/g; and crystals of aripiprazole lauroxil produced by such processes.
    Type: Application
    Filed: July 24, 2018
    Publication date: January 17, 2019
    Inventors: Wilfredo Morales, JR., Tarek A. Zeidan, Renato A. Chiarella, Steven G. Wright, Jason M. Perry
  • Crystallization process of aripiprazole derivatives in extended release formulations for treatment of schizophrenia
    Patent number: 10064859
    Abstract: Processes for providing depot injections of recrystallized aripiprazole lauroxil in which particles of the aripiprazole lauroxil have a surface area of about 0.50 to about 3.3 m2/g; and crystals of aripiprazole lauroxil produced by such processes.
    Type: Grant
    Filed: August 24, 2015
    Date of Patent: September 4, 2018
    Assignee: ALKERMES PHARMA IRELAND LIMITED
    Inventors: Wilfredo Morales, Jr., Tarek A. Zeidan, Renato A. Chiarella, Steven G. Wright, Jason M. Perry
  • CRYSTALLIZATION PROCESS OF ARIPIPRAZOLE DERIVATIVES IN EXTENDED RELEASE FORMULATIONS FOR TREATMENT OF SCHIZOPHRENIA
    Publication number: 20160051546
    Abstract: Processes for providing depot injections of recrystallized aripiprazole lauroxil in which particles of the aripiprazole lauroxil have a surface area of about 0.50 to about 3.3 m2/g; and crystals of aripiprazole lauroxil produced by such processes.
    Type: Application
    Filed: August 24, 2015
    Publication date: February 25, 2016
    Inventors: Wilfredo Morales, JR., Tarek A. Zeidan, Renato A. Chiarella, Steven G. Wright, Jason M. Perry
  • NOVEL CRYSTAL OF N-[[(5S)-3-[4-(2,6-DIHYDRO-2-METHYLPYRROLO[3,4-C]PYRAZOL-5(4H)-YL)-3-FLUOROPHENYL]-2-OXO-5-OXAZOLIDINYL]METHYL]ACETAMIDE
    Publication number: 20080091026
    Abstract: The present invention relates to a novel crystal of the Active Pharmaceutical Ingredient (API) N-[[(5S)-3 -[4-(2,6-dihydro-2-methylpyrrolo[3,4-c]pyrazol-5(4H)-yl)-3-fluorophenyl]-2-oxo-5-oxazolidinyl]methyl]acetamide, methods for the preparation of this crystal, pharmaceutical compositions comprising this crystal, and methods of treating a patient with this crystal.
    Type: Application
    Filed: October 10, 2007
    Publication date: April 17, 2008
    Applicant: TRANSFORM PHARMACEUTICALS, INC.
    Inventors: Renato Chiarella, Matthew Peterson, Lisa Scoppettuolo